2 |
Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, Furukawa TA, Kessler RC, Kohrt BA, Maj M, Mcgorry P, Reynolds CF, Weissman MM, Chibanda D, Dowrick C, Howard LM, Hoven CW, Knapp M, Mayberg HS, Penninx BWJH, Xiao S, Trivedi M, Uher R, Vijayakumar L, Wolpert M. Time for united action on depression: a Lancet–World Psychiatric Association Commission. The Lancet 2022;399:957-1022. [DOI: 10.1016/s0140-6736(21)02141-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Kessler RC, Furukawa TA, Kato T, Luedtke A, Petukhova M, Sadikova E, Sampson NA. An individualized treatment rule to optimize probability of remission by continuation, switching, or combining antidepressant medications after failing a first-line antidepressant in a two-stage randomized trial. Psychol Med 2021;:1-10. [PMID: 33682648 DOI: 10.1017/S0033291721000027] [Reference Citation Analysis]
|